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ments occurred at the following time-points: CK MB 14 hrs, myoglobin 8 hrs, troponin-T and 
troponin-116 hrs. Only myoglobin fell to normal within 48 hrs. 
Conclusion. This is the first human study to track the time course of cardiac serum marker 
release following a MI when the precise timing of vessel closure was known. Our results are 
consistent with previous human studies of marker elevation after MI symptom onset. There- 
fore, symptom onset appears to be a reliable surrogate for vessel closure in an acute MI. 
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disease with 1500 to 2000 patient admissions per year. 
Methods: We retrospectively reviewed charts of patients with ICD-9 codes (International 
Classification of Disease, 9th Revision) for HIV disease and acute coronary syndromes 
at our hospital between January 1996 and December 2000. Fifty patients with either 
unstable angina or myocardial infarction were identified. This represented approximately 
0.6% of all HIV patient admissions during that time period. 
Results: Of the standard cardiovascular dsk factors, one or more were present in 88% of 
the patients and only 5 patients were recently using cocaine. Forty-five (90%) of the 
patients were men and the mean age was 49 + 9 years. The average duration since diag- 
nosis of HIV infection was 7.8 _+ 4.7 years, the average CD4 count was 426 + 290 x 103 
and twenty-nine (58%) were taking protease inhibitors. Forty-five (90%) underwent car- 
diac catheterization during admission and 40 had significant (>50% diameter stenosis) 
coronary artery disease (42% with 1-vessel disease). Patients with (n=21) or without pro- 
tease inhibitor (n=29) use were not significantly different in clinical, demographic or 
angiographic characteristics. Twenty-five (50%) underwent percutaneous coronary inter- 
vention and 9 (18%) other patients had a coronary artery bypass graft surgery with an 
overall in-hospital mortality of 2.9% (0% in percutaneous coronary intervention). 
Conclusion: In a large population of patients with HIV disease, admission for acute cor- 
onary syndromes is uncommon. This descriptive study indicates that nearly all have one 
or more traditional risk factors. Peroutaneous coronary intervention or coronary artery 
bypass graft surgery cna be done safely with a low in-hospital mortality. Controlled, pro- 
spective data are required to assess if there is any direct association between HIV dis- 
ease and acute coronary syndromes. 
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840-1 Nonwhite Race Is Associated With a Higher Rate of 
Death and Ischemic Complications in Patients With 
Acute Coronary Syndromes Despite Modern Early 
Invasive Treatment 
Marc S. Sabatine. Gavin J. Blake, Mark H. Drazner, David A. Morrow, Laura A. 
Demopoulos, Peter M. DiBattiste, Carolyn H. McCabe, Christopher P. Cannon, Eugene 
Braunwald, Brigham and Women's Hospital Boston, Massachusetts. 
Background: In administrative databases and registries, nonwhite patients have been 
shown to be less likely to undergo invasive procedures and to have higher rates of 
adverse cardiac events. We sought to determine the association between race and out- 
come in patients with UNNSTEMI receiving modern therapy in a clinicai trial. 
Methods & Results: Of 2220 patients in TACTICS-TIM118, 498 were nonwhite (22.4%). 
Alt patients received aspirin, heparin, and upstream tirofiban and were randomized to 
invasive (INV) vs. conservative (CONS) management. In a Cox proportional hazards 
model that adjusted for confounders (including age, sex, cardiac risk factors, prior car- 
diac disease, ST deviation, and treponin elevation), nonwhite patients were at signifi- 
cantly increased risk for the composite endpoint of death, MI, or rehospitalization for ACS 
[hazard ratio (HR) 1.34, p=0.026]. When stratified by randomized treatment assignment, 
in the CONS arm there was no difference in outcome (HR for nonwhite patients 1.14, 
p=0.5), but in the INV arm nonwhite patients were at significantly higher risk (HR=1.70, 
p=0.005). Inclusion of angiographic extent of CAD and LVEF into the Cox model for 
patients in the INV arm did not diminish the increased risk associated with nonwhite race 
(HR=1.88, p=0.006), 
Conclusion: In UNNSTEMI, nonwhite patients assigned to invasive therapy are at sig- 
nificantly higher risk for death and ischemic complications. The reasons for this disparity 
are unclear and warrant further exploration. 
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840-2 HIV Disease and Acute Coronary Syndromes 
Randv B. Gould, Nioole B. Pearlstein, Mary C. De Voe, John T. Coppola, Frederick P. 
Siega[, John A. Ambrose, Saint Vincent Catholic Medical Centers of New York - 
Manhattan Division, New York, New York. 
Background: Sporadic cases have been reported of the association between HIV dis- 
ease and acute myocardial infarction. There are no large series and the response to 
interventional techniques is unknown. Our hospital center is a large referral base for HIV 
840-3 Benef i t  o f  Invasive Strategy for Women With Acute 
Coronary Syndromes: Observations From the TACTICS- 
TIMI 18 Trial 
Ruchira Glaser, Howard C. Herrmann, Sabina A. Murphy, Laura A. Demopoulos, Peter 
M. DiBattiste, Christopher P. Cannon, Eugene Braunwald, University of Pennsylvania 
Medical Center, Philade/phia, Pennsylvania, Brigham and Women's Hospital, Boston, 
Massachusetts. 
Background: Women with acute coronary syndromes (ACS) in the FRISC II trial had a 
worse outcome with invasive (INV) versus conservative (CON) management. However, 
this and other studies of management in ACS were performed before widespread use of 
glycopretein lib/Ilia inhibitors and stents. 
Methods: We compared the baseline characteristics and primary endpoint (death, MI, 
rehospitalization for ACS by 6 months) of 757 women and 1463 men treated with 
tirofiban and randomized to INV versus CON strategy in the TACTICS-TIM118 study. 
Results: Women were older, smoked less, and had less prior MI and coronary artery 
bypass grafting (CABG). Women presented less often with elevated cardiac markers, but 
there was no difference between men and women in TIMI risk score. Angiography and 
intervention rates were similar, but women had less severe CAD, including no critical 
lesions in 17% vs 9% of men (p<0.001). CABG rates were lower in women(15% vs 22% 
of men, p=0.003), but 30-day surgical mortality rates were similar. Finally, women and 
men had similar benefit from an early INV strategy (interaction p for gender = 0.6). The 
benefit was greatest in women with elevated troponin (primary endpoint of 18.6% vs 
29.0% in INV and CON arms, respectively, p=0.03) (see figure). 
Conclusions: Women with ACS had more risk factors than men and similar TIMI risk 
scores, but had less severe CAD. The benefit of tirofiban combined with an early INV 
strategy was similar in women and men, and enhanced in women presenting with ele- 
vated troponin T levels. 
~4H 
9:15 a.m. 
840-4 Dramatic Increase in 30-Day Morta l i ty  in Diabetic 
Patients With Non-ST Segment Elevation Acute 
Coronary Syndromes 
Marco Roffi. Leslie Cho, Deepak L Bhatt, Jennifer A. White, David J. Molitemo, Robed 
A. Harringtoo, Eric J. Topoi, The Cleveland Clinic Foundation, Cleveland, Ohio, Duke 
Clinical Research Institute, Durham, North Carolina. 
Background: Limited data. are available on outcome of diabetic patients presenting with 
non-ST-segment elevation acute coronary syndromes. Methods: We performed a 
pooled analysis of 4 glycoprotein nb/llla inhibitor-acute coronary syndrome tnals, PARA- 
GON A, PARAGON B, PURSUIT, and GUSTO IV, and addressed the impact of diabetes 
on 30-day mortality. Results: The Kaplan-Meier curves for 30-day mortality in diabetics 
and nondiabetics are shown in the Figure. Multivariate analysis demonstrated that diabe- 
tes was an independent predictor of mortality in the overall study population (hazard ratio 
1 38, p<0.001). Subgroup analysis among diabetic patients demonstrated following 30- 
day mortality rates: 7.7% for age >65 years vs. 2.7% for age ~ 65 years (p<0.001); 6.5% 
for insulin-dependent vs. 5.1% for non-insulin-dependent (p<0.037); 12.6% for creatinine 
>1.5 mg/dt vs. 4.8% for croatinine _< 1.5 rag/all (p<0.001). In a multivariate regression 
model, reduced renal function, ST-segment depression on ECG, insulin dependent dia- 
betes, and history of congestive heart failure, were all significant independent predictors 
